✦ LIBER ✦

Refuting the Ticagrelor-Aspirin Black Box Warning: And Proposing a Ticagrelor Early-PCI Black Box Warning

✍ Scribed by DiNicolantonio, James J.; Serebruany, Victor L.; Tomek, Ales

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Challenging the FDA Black Box Warning fo

✍ DiNicolantonio, J. J.; Serebruany, V. L. 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 59 KB

Impact of the FDA Black Box Warning on P

✍ Lineberry, Timothy W.; Bostwick, J. Michael; Beebe, Timothy J.; Decker, Paul A. 📂 Article 📅 2007 🏛 Mayo Clinic 🌐 English ⚖ 41 KB

Use of Droperidol at ERCP and QTc Prolon

✍ Panot Yimcharoen; Evan L. Fogel; Lee McHenry; James L. Watkins; Stephen Rosenfel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 48 KB

“Product Safety” Compromises Patient Saf

✍ Paul A. Grayburn 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Pediatric Primary Care Providers and Ado

✍ Laura P. Richardson; Charlotte W. Lewis; Mary Casey-Goldstein; Elizabeth McCaule 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Depot Medroxyprogesterone Acetate and Bo

✍ Barbara A. Cromer; Delia Scholes; Abbey Berenson; Tim Cundy; M. Kathleen Clark; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 99 KB